Ann Barbier

3.6k citations

66 papers · 2.8k indexed · 2 hit papers · h-index 29

Impact in

Sensory Systems top 2%
- Olfactory and Sensory Function Studies
Immunology top 5%
- Mast cells and histamine
- Immunotherapy and Immune Responses

Papers in

Sensory Systems 7
- Olfactory and Sensory Function Studies 7
Endocrine and Autonomic Systems 6

Co-authors: Peng ZhangAllen Yujie Jiang Daniel G. Anderson Sandy J. Wilson Romain A. Lefebvre Timothy W. Lovenberg Nicholas I. Carruthers Jamin D. Boggs
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)Molecular Genetics and Metabolism (6 papers)European Journal of Pharmacology (5 papers)Trends in Pharmacological Sciences (5 papers)British Journal of Pharmacology (5 papers)
Partner nations: United States United Kingdom Belgium

In The Last Decade

Ann Barbier

64 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study 2023 · 82 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Journal of Cystic Fibrosis
2022 Nature Biotechnology

Peers

Countries citing papers authored by Ann Barbier

Since Specialization

Citations

This map shows the geographic impact of Ann Barbier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Barbier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Barbier more than expected).

Fields of papers citing papers by Ann Barbier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Barbier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Barbier. The network helps show where Ann Barbier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ann Barbier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann Barbier Line = papers co-authored together Ann Barbier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study Journal of Cystic Fibrosis ·Steven M. Rowe, Jonathan B. Zuckerman, Daniel Dorgan, Jorge Lascano, Karen McCoy, Manu Jain, Michael S. Schechter, L. Moya, Kévin Varrall, Noah Lechtzin, Kimberly McBennett, Busche Fw, Cynthia D. Brown, Theodore G. Liou, Kelvin D. MacDonald, Samya Z. Nasr, Shaharom Md Shariff, Nazlı Özdemir, Eric B. Meltzer, Ann Barbier Hit paper breakdown →	2023	82
2	The clinical progress of mRNA vaccines and immunotherapies Nature Biotechnology ·Ann Barbier, Allen Yujie Jiang, Peng Zhang, DAISY MENDONÇA, Daniel G. Anderson Hit paper breakdown →	2022	530
3	Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency Blood ·Rachael F. Grace, D. Mark Layton, Frédéric Galactéros, Christian Rosé, Wilma Barcellini, D. Holmes Morton, Eduard J. van Beers, Hassan M. Yaish, Yaddanapudi Ravindranath, Kevin H.M. Kuo, Sujit Sheth, Janet L. Kwiatkowski, Bruce A. Silver, Charles Kung, Marvin B. Cohen, Hua Yang, Penelope A. Kosinski, Lei Hua, Ann Barbier, Bertil Glader	2017	2
4	Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions Molecular Genetics and Metabolism ·Elsa Shapiro, 이유림, Heather Adams, Ann Barbier, Teresa Buracchio, Peter G. Como, Kathleen Delaney, Florian Eichler, Jonathan C. Goldsmith, Juan Tonheiro, Satu Jalonen, Jonathan W. Mink, Joanne Odenkirchen, Melissa A. Parisi, Alison Skrinar, Susan E. Waisbren, Andrew E. Mulberg	2016	26
5	Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment SHILAP Revista de lepidopterología ·Christian J. Hendriksz, Joseph Muenzer, Adeline Vanderver, Jonathan M. Davis, Barbara K. Burton, Nancy J. Mendelsohn, Nan Wang, Luying Pan, Arian Pano, Ann Barbier	2015	27
6	Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective α7 Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies Clinical Therapeutics ·Ann Barbier, Henk W. M. Hilhorst, André van Vliet, Peter J. Snyder, Michael G. Palfreyman, Maria S. Gawryl, Nancy Dgetluck, Monica Massaro, Renger G. Tiessen, Wia Timmerman, Dana Hilt	2014	39
7	The relationship between anti-idursulfase antibody status and safety and efficacy outcomes in attenuated mucopolysaccharidosis II patients aged 5years and older treated with intravenous idursulfase Molecular Genetics and Metabolism ·Ann Barbier, 曹哲, David Whiteman, Madhusudan Natarajan, Arian Pano, David A. Amato	2013	43
8	Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors Bioorganic & Medicinal Chemistry Letters ·Michael A. Letavic, Emily M. Stocking, Ann Barbier, Pascal Bonaventure, Jamin D. Boggs, Brian Lord, Kirsten L. Miller, Sandy J. Wilson, Nicholas I. Carruthers	2007	9
9	Lead identification of acetylcholinesterase inhibitors–histamine H3 receptor antagonists from molecular modeling Bioorganic & Medicinal Chemistry ·Scott D. Bembenek, John M. Keith, Michael A. Letavic, Richard L. Apodaca, Ann Barbier, Lisa Dvorak, Leah Aluisio, Kirsten L. Miller, Timothy W. Lovenberg, Nicholas I. Carruthers	2007	48
10	Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors Bioorganic & Medicinal Chemistry Letters ·Kiev S. Ly, Michael A. Letavic, John M. Keith, LUCIOLA CRUZ PAIVA TISI, Emily M. Stocking, Ann Barbier, Pascal Bonaventure, Brian Lord, Xiaohui Jiang, Jamin D. Boggs, Lisa Dvorak, Kirsten L. Miller, Diane Nepomuceno, Sandy J. Wilson, Nicholas I. Carruthers	2007	19
11	Subcellular Localization and Biological Actions of Activated RSK1 Are Determined by Its Interactions with Subunits of Cyclic AMP-Dependent Protein Kinase Molecular and Cellular Biology ·Deepti Chaturvedi, Helen Poppleton, 政行伊藤, Ann Barbier, Tarun B. Patel	2006	42
12	Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore Bioorganic & Medicinal Chemistry Letters ·John M. Keith, A. M. Reid, Michael A. Letavic, Kiev S. Ly, Jill A. Jablonowski, Mark Seierstad, Ann Barbier, Sandy Wilson, Jamin D. Boggs, Ian Fraser, Curt Mazur, (unknown), Nicholas I. Carruthers	2006	0
13	5 Recent Medicinal Chemistry of the Histamine H3 Receptor Progress in medicinal chemistry ·Michael A. Letavic, Ann Barbier, Curt A. Dvorak, Nicholas I. Carruthers	2006	36
14	Effects of histamine H3 antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice Neuropharmacology ·Feiyong Jia, Motohisa Kato, Hongmei Dai, K. R. Credeur, Tomohiro Okuda, Eiko Sakurai, Nobuyuki Okamura, Timothy W. Lovenberg, Ann Barbier, Nicholas I. Carruthers, Kazuie Iinuma, Kazuhiko Yanai	2005	28
15	A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase Analytical Biochemistry ·Sandy J. Wilson, Timothy W. Lovenberg, Ann Barbier	2003	27
16	Functional Analyses of Type V Adenylyl Cyclase Methods in enzymology on CD-ROM/Methods in enzymology ·Tarun B. Patel, Chongying Zhang, Ann Barbier, Yinges Yigzaw, Klaus Scholich	2002	4
17	Influence of S‐nitrosothiols and nitrate tolerance in the rat gastric fundus British Journal of Pharmacology ·Ann Barbier, R A Lefebvre	1994	28
18	Involvement of the L-arginine: nitric oxide pathway in nonadrenergic noncholinergic relaxation of the cat gastric fundus. Journal of Pharmacology and Experimental Therapeutics ·Ann Barbier, Romain A. Lefebvre	1993	40
19	Effect of 3-isobutyl-1-methylxanthine and zaprinast on non-adrenergic non-cholinergic relaxation in the rat gastric fundus European Journal of Pharmacology ·Ann Barbier, Romain A. Lefebvre	1992	17
20	Orthotopic Liver Transplantation in Pigs without Cold Perfusion of the Donor Liver European Surgical Research ·Neelam Soni, H. Eckelt, Hans E. Wagner, Ann Barbier, Daniel Mettler	1986	8

About Ann Barbier

Ann Barbier is a scholar working on Sensory Systems, Endocrine and Autonomic Systems, Immunology, Physiology and Applied Microbiology and Biotechnology, having authored 66 papers that have together received 2.8k indexed citations. Recurring topics across this work include Mast cells and histamine (16 papers), Receptor Mechanisms and Signaling (11 papers), Lysosomal Storage Disorders Research (8 papers), Olfactory and Sensory Function Studies (7 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Glycogen Storage Diseases and Myoclonus (5 papers). The work is most often cited by research in Sensory Systems (248 citations), Immunology (756 citations), Endocrine and Autonomic Systems (237 citations), Toxicology (100 citations) and Physiology (729 citations). Ann Barbier has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Peng Zhang, Allen Yujie Jiang, Daniel G. Anderson, Sandy J. Wilson, Romain A. Lefebvre, Timothy W. Lovenberg, Nicholas I. Carruthers, Jamin D. Boggs, Tarun B. Patel and R A Lefebvre. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Genetics and Metabolism, European Journal of Pharmacology, Trends in Pharmacological Sciences and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact